Eagle Pharmaceuticals, Inc.Eagle Pharmaceuticals, Inc.Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪50.00 M‬USD
‪35.64 M‬USD
‪316.61 M‬USD
‪11.43 M‬
Beta (1Y)
−0.40

About Eagle Pharmaceuticals, Inc.

CEO
Michael Graves
Headquarters
Woodcliff Lake
Employees (FY)
135
Founded
2007
FIGI
BBG005Y3XWH9
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EGRX is 3.85 USD — it has increased by 0.79% in the past 24 hours. Watch Eagle Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Eagle Pharmaceuticals, Inc. stocks are traded under the ticker EGRX.
EGRX stock has risen by 3.22% compared to the previous week, the month change is a 18.95% fall, over the last year Eagle Pharmaceuticals, Inc. has showed a 78.73% decrease.
EGRX reached its all-time high on Aug 5, 2015 with the price of 104.17 USD, and its all-time low was 3.21 USD and was reached on May 29, 2024. View more price dynamics on EGRX chart.
See other stocks reaching their highest and lowest prices.
EGRX stock is 4.79% volatile and has beta coefficient of −0.40. Track Eagle Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Eagle Pharmaceuticals, Inc. there?
Today Eagle Pharmaceuticals, Inc. has the market capitalization of ‪50.00 M‬, it has decreased by 2.62% over the last week.
Yes, you can track Eagle Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Eagle Pharmaceuticals, Inc. is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
No, EGRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 16, 2024, the company has 135.00 employees. See our rating of the largest employees — is Eagle Pharmaceuticals, Inc. on this list?
Like other stocks, EGRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eagle Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eagle Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eagle Pharmaceuticals, Inc. stock shows the sell signal. See more of Eagle Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.